世界の副腎皮質ホルモン阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Adrenal Corticosteroid Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3766
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、88ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、副腎皮質ホルモン阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オシロドロスタット、メチラポン）、用途別市場規模（病院、ホームケア、専門センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・副腎皮質ホルモン阻害剤の市場動向
・企業の競争状況、市場シェア
・副腎皮質ホルモン阻害剤の種類別市場規模と予測2016-2027（オシロドロスタット、メチラポン）
・副腎皮質ホルモン阻害剤の用途別市場規模と予測2016-2027（病院、ホームケア、専門センター、その他）
・副腎皮質ホルモン阻害剤の北米市場規模2016-2027（アメリカ、カナダ）
・副腎皮質ホルモン阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・副腎皮質ホルモン阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・副腎皮質ホルモン阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・副腎皮質ホルモン阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis、Recordati、HRA Pharma）
・結論

Adrenal corticosteroid inhibitors are a class of therapeutic drugs that are widely used to treat Cushing’s syndrome and certain types of solid tumors, such as breast cancer. It exerts its effect by inhibiting the endogenous synthesis of hormones secreted by the adrenal cortex by interfering with the enzyme responsible for the steroid synthesis pathway.

Market Analysis and Insights: Global Adrenal Corticosteroid Inhibitors Market
The global Adrenal Corticosteroid Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adrenal Corticosteroid Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adrenal Corticosteroid Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adrenal Corticosteroid Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adrenal Corticosteroid Inhibitors market.

Global Adrenal Corticosteroid Inhibitors Scope and Market Size
Adrenal Corticosteroid Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adrenal Corticosteroid Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Osilodrostat
Metyrapone

Segment by Application
Hospitals
Home Care
Speciality Centres
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Recordati
HRA Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adrenal Corticosteroid Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Osilodrostat
1.2.3 Metyrapone
1.3 Market by Application
1.3.1 Global Adrenal Corticosteroid Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Home Care
1.3.4 Speciality Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Adrenal Corticosteroid Inhibitors Market Perspective (2016-2027)
2.2 Adrenal Corticosteroid Inhibitors Growth Trends by Regions
2.2.1 Adrenal Corticosteroid Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adrenal Corticosteroid Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Adrenal Corticosteroid Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Adrenal Corticosteroid Inhibitors Industry Dynamic
2.3.1 Adrenal Corticosteroid Inhibitors Market Trends
2.3.2 Adrenal Corticosteroid Inhibitors Market Drivers
2.3.3 Adrenal Corticosteroid Inhibitors Market Challenges
2.3.4 Adrenal Corticosteroid Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Adrenal Corticosteroid Inhibitors Players by Revenue
3.1.1 Global Top Adrenal Corticosteroid Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Adrenal Corticosteroid Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Adrenal Corticosteroid Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adrenal Corticosteroid Inhibitors Revenue
3.4 Global Adrenal Corticosteroid Inhibitors Market Concentration Ratio
3.4.1 Global Adrenal Corticosteroid Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adrenal Corticosteroid Inhibitors Revenue in 2020
3.5 Adrenal Corticosteroid Inhibitors Key Players Head office and Area Served
3.6 Key Players Adrenal Corticosteroid Inhibitors Product Solution and Service
3.7 Date of Enter into Adrenal Corticosteroid Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Adrenal Corticosteroid Inhibitors Breakdown Data by Type
4.1 Global Adrenal Corticosteroid Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Adrenal Corticosteroid Inhibitors Forecasted Market Size by Type (2022-2027)

5 Adrenal Corticosteroid Inhibitors Breakdown Data by Application
5.1 Global Adrenal Corticosteroid Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Adrenal Corticosteroid Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Adrenal Corticosteroid Inhibitors Market Size (2016-2027)
6.2 North America Adrenal Corticosteroid Inhibitors Market Size by Type
6.2.1 North America Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2027)
6.3 North America Adrenal Corticosteroid Inhibitors Market Size by Application
6.3.1 North America Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2027)
6.4 North America Adrenal Corticosteroid Inhibitors Market Size by Country
6.4.1 North America Adrenal Corticosteroid Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Adrenal Corticosteroid Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Adrenal Corticosteroid Inhibitors Market Size (2016-2027)
7.2 Europe Adrenal Corticosteroid Inhibitors Market Size by Type
7.2.1 Europe Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2027)
7.3 Europe Adrenal Corticosteroid Inhibitors Market Size by Application
7.3.1 Europe Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2027)
7.4 Europe Adrenal Corticosteroid Inhibitors Market Size by Country
7.4.1 Europe Adrenal Corticosteroid Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Adrenal Corticosteroid Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Type
8.2.1 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Application
8.3.1 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Region
8.4.1 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Adrenal Corticosteroid Inhibitors Market Size (2016-2027)
9.2 Latin America Adrenal Corticosteroid Inhibitors Market Size by Type
9.2.1 Latin America Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Adrenal Corticosteroid Inhibitors Market Size by Application
9.3.1 Latin America Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Adrenal Corticosteroid Inhibitors Market Size by Country
9.4.1 Latin America Adrenal Corticosteroid Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Adrenal Corticosteroid Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Type
10.2.1 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Application
10.3.1 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Country
10.4.1 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Adrenal Corticosteroid Inhibitors Introduction
11.1.4 Novartis Revenue in Adrenal Corticosteroid Inhibitors Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Recordati
11.2.1 Recordati Company Details
11.2.2 Recordati Business Overview
11.2.3 Recordati Adrenal Corticosteroid Inhibitors Introduction
11.2.4 Recordati Revenue in Adrenal Corticosteroid Inhibitors Business (2016-2021)
11.2.5 Recordati Recent Development
11.3 HRA Pharma
11.3.1 HRA Pharma Company Details
11.3.2 HRA Pharma Business Overview
11.3.3 HRA Pharma Adrenal Corticosteroid Inhibitors Introduction
11.3.4 HRA Pharma Revenue in Adrenal Corticosteroid Inhibitors Business (2016-2021)
11.3.5 HRA Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Adrenal Corticosteroid Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Osilodrostat
Table 3. Key Players of Metyrapone
Table 4. Global Adrenal Corticosteroid Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Adrenal Corticosteroid Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Adrenal Corticosteroid Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Adrenal Corticosteroid Inhibitors Market Share by Regions (2016-2021)
Table 8. Global Adrenal Corticosteroid Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Adrenal Corticosteroid Inhibitors Market Share by Regions (2022-2027)
Table 10. Adrenal Corticosteroid Inhibitors Market Trends
Table 11. Adrenal Corticosteroid Inhibitors Market Drivers
Table 12. Adrenal Corticosteroid Inhibitors Market Challenges
Table 13. Adrenal Corticosteroid Inhibitors Market Restraints
Table 14. Global Adrenal Corticosteroid Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Adrenal Corticosteroid Inhibitors Market Share by Players (2016-2021)
Table 16. Global Top Adrenal Corticosteroid Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenal Corticosteroid Inhibitors as of 2020)
Table 17. Ranking of Global Top Adrenal Corticosteroid Inhibitors Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Adrenal Corticosteroid Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adrenal Corticosteroid Inhibitors Product Solution and Service
Table 21. Date of Enter into Adrenal Corticosteroid Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Adrenal Corticosteroid Inhibitors Revenue Market Share by Type (2016-2021)
Table 25. Global Adrenal Corticosteroid Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Adrenal Corticosteroid Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Adrenal Corticosteroid Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Adrenal Corticosteroid Inhibitors Revenue Market Share by Application (2016-2021)
Table 29. Global Adrenal Corticosteroid Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Adrenal Corticosteroid Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Adrenal Corticosteroid Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Adrenal Corticosteroid Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Adrenal Corticosteroid Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Adrenal Corticosteroid Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Adrenal Corticosteroid Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Adrenal Corticosteroid Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Adrenal Corticosteroid Inhibitors Product
Table 64. Novartis Revenue in Adrenal Corticosteroid Inhibitors Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Recordati Company Details
Table 67. Recordati Business Overview
Table 68. Recordati Adrenal Corticosteroid Inhibitors Product
Table 69. Recordati Revenue in Adrenal Corticosteroid Inhibitors Business (2016-2021) & (US$ Million)
Table 70. Recordati Recent Development
Table 71. HRA Pharma Company Details
Table 72. HRA Pharma Business Overview
Table 73. HRA Pharma Adrenal Corticosteroid Inhibitors Product
Table 74. HRA Pharma Revenue in Adrenal Corticosteroid Inhibitors Business (2016-2021) & (US$ Million)
Table 75. HRA Pharma Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adrenal Corticosteroid Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Osilodrostat Features
Figure 3. Metyrapone Features
Figure 4. Global Adrenal Corticosteroid Inhibitors Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Home Care Case Studies
Figure 7. Speciality Centres Case Studies
Figure 8. Others Case Studies
Figure 9. Adrenal Corticosteroid Inhibitors Report Years Considered
Figure 10. Global Adrenal Corticosteroid Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Adrenal Corticosteroid Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Adrenal Corticosteroid Inhibitors Market Share by Regions: 2020 VS 2027
Figure 13. Global Adrenal Corticosteroid Inhibitors Market Share by Regions (2022-2027)
Figure 14. Global Adrenal Corticosteroid Inhibitors Market Share by Players in 2020
Figure 15. Global Top Adrenal Corticosteroid Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adrenal Corticosteroid Inhibitors as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Adrenal Corticosteroid Inhibitors Revenue in 2020
Figure 17. Global Adrenal Corticosteroid Inhibitors Revenue Market Share by Type (2016-2021)
Figure 18. Global Adrenal Corticosteroid Inhibitors Revenue Market Share by Type (2022-2027)
Figure 19. North America Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Adrenal Corticosteroid Inhibitors Market Share by Type (2016-2027)
Figure 21. North America Adrenal Corticosteroid Inhibitors Market Share by Application (2016-2027)
Figure 22. North America Adrenal Corticosteroid Inhibitors Market Share by Country (2016-2027)
Figure 23. United States Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Adrenal Corticosteroid Inhibitors Market Share by Type (2016-2027)
Figure 27. Europe Adrenal Corticosteroid Inhibitors Market Share by Application (2016-2027)
Figure 28. Europe Adrenal Corticosteroid Inhibitors Market Share by Country (2016-2027)
Figure 29. Germany Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Adrenal Corticosteroid Inhibitors Market Share by Region (2016-2027)
Figure 39. China Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Adrenal Corticosteroid Inhibitors Market Share by Type (2016-2027)
Figure 47. Latin America Adrenal Corticosteroid Inhibitors Market Share by Application (2016-2027)
Figure 48. Latin America Adrenal Corticosteroid Inhibitors Market Share by Country (2016-2027)
Figure 49. Mexico Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Adrenal Corticosteroid Inhibitors Market Share by Country (2016-2027)
Figure 55. Turkey Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Adrenal Corticosteroid Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Novartis Revenue Growth Rate in Adrenal Corticosteroid Inhibitors Business (2016-2021)
Figure 59. Recordati Revenue Growth Rate in Adrenal Corticosteroid Inhibitors Business (2016-2021)
Figure 60. HRA Pharma Revenue Growth Rate in Adrenal Corticosteroid Inhibitors Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5611 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年）

Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5815 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ヤヌスキナーゼ（JAK）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ）、用途別市場規模（自己免疫疾患、腫瘍）、主要...

世界のB細胞リンパ腫2阻害剤市場規模・現状・予測（2021年-2027年）

Global B-cell lymphoma 2 Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5610 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、B細胞リンパ腫2阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病）、主要地域別市場規模（北米、アメ...

世界のがんCDK阻害剤市場規模・現状・予測（2021年-2027年）

Global Cancer CDK Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-3953 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、がんCDK阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（前臨床、フェーズI、フェーズI / II、フェーズII、フェーズIII）、用途別市場規模（医療機関、科学研究センター）、主要地域別市場規...

世界のヘッジホッグ経路阻害剤市場規模・現状・予測（2021年-2027年）

Global Hedgehog Pathway Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-4292 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、ヘッジホッグ経路阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビスモデギブ、エリスモデギブ、その他）、用途別市場規模（基底細胞癌（BCC）、急性リンパ芽球性白血病（AML）、その他）、主要地域...

世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年）

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5949 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、PI3キナーゼ（PI3K）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）、用途別市場規模（病院、研究所・研究機関、クリニック、その...

世界の選択的セロトニン再取り込み阻害薬（SSRI）市場規模・現状・予測（2021年-2027年）

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and Forecast 2021-2027
QFJ1-6005 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シタロプラム（セレクサ）、エスシタロプラム（レクサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシ...

世界のアンジオテンシン変換酵素阻害剤市場規模・現状・予測（2021年-2027年）

Global Angiotensin Converting Enzyme Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-3807 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、アンジオテンシン変換酵素阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベナゼプリル（ロテンシン）、カプトプリル、エナラプリル（バソテック）、フォシノプリル、リシノプリル（プリニビル、ゼストリル...

世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場規模・現状・予測（2021年-2027年）

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5932 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オラパリブ、タラゾパリブ）、用途別市場規模（卵巣がん、乳がん、その他）、主要地域別市場規模（北米、アメリ...

世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年） Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels. The vascular endothelial growth factor is a protein that can trigger endothelial cells or pre-existing vessels to form new blood vessels. However, overexpression of …
世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年） Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. Market Analysis and Insights: Global BCL-2 (B-cell lympho…
世界のイソクエン酸デヒドロゲナーゼ阻害剤市場規模・現状・予測（2021年-2027年） Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (α-ketoglutarate) and CO2. Specific mutations in the isocitrate dehydrogenase gene IDH1 have been found in several brain tumors includ…
世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年） JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy in the treatment of various chronic diseases. The high unmet need for the treatment of graft-versus-host disease (GVHD) has also encouraged market vend…